Clincosm LogoSign in Get a demo

Pharmacokinetics

Showing 26 - 50 of 417
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics Trial in Oslo (GE200486 0.5M Injection)

Completed
  • Pharmacokinetics
  • GE200486 0.5M Injection
  • Oslo, Norway
    Rikshospitalet
Dec 29, 2022

Pharmacokinetics, Food Affect, Single Ascending Dose Trial in Changchun (GST-HG121 tablets, Placebo)

Recruiting
  • Pharmacokinetics
  • +3 more
  • GST-HG121 tablets
  • Placebo
  • Changchun, Jilin, China
    The first hospital of Jilin University
Dec 26, 2022

Febrile Neutropenia, Pharmacokinetics, Pharmacodynamic Trial (Dose prediction using population pharmacokinetic models)

Not yet recruiting
  • Febrile Neutropenia
  • +3 more
  • Dose prediction using population pharmacokinetic models
  • (no location specified)
Dec 23, 2022

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Safety Issues, Pharmacokinetics, Drug Interaction Trial in Uppsala (Linaprazan glurate, Drug drug interaction (DDI) -

Recruiting
  • Safety Issues
  • +3 more
  • Linaprazan glurate
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trials Consultants AB
Dec 19, 2022

Pharmacodynamics, Pharmacokinetics, Bioequivalence Trial in Yaroslavl (GP40141, Nplate)

Recruiting
  • Pharmacodynamics
  • +2 more
  • Yaroslavl, Russian Federation
    Yaroslavl Region "Clinical Hospital No. 3", ,, Mayakovskogo st.,
Dec 14, 2022

Pharmacokinetics, Safety Issues, Efficacy Trial in Russian Federation (GP30341 capsules 200 mg, Standard therapy)

Completed
  • Pharmacokinetics
  • +2 more
  • GP30341 capsules 200 mg
  • Standard therapy
  • Kaliningrad, Russian Federation
  • +4 more
Dec 7, 2022

Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)

Completed
  • Pharmacokinetics
  • WCK 2349 Oral
  • Placebo Oral
  • (no location specified)
Nov 28, 2022

Pharmacokinetics Trial in Seoul (IY-NT-T, IY-NT-R)

Recruiting
  • Pharmacokinetics
  • Seoul, Gwanak-gu, Korea, Republic of
    H plus Yangji Hospital
Nov 8, 2022

Pharmacokinetics Trial in Burnaby (Quercetin LipoMicel (250 mg), Quercetin LipoMicel (500 mg), Quercetin LipoMicel (1000 mg))

Completed
  • Pharmacokinetics
  • Quercetin LipoMicel (250 mg)
  • +3 more
  • Burnaby, British Columbia, Canada
    ISURA
Nov 3, 2022

Pharmacokinetics, Bioequivalence Trial in Dallas (Sumatriptan (via Intraject System))

Completed
  • Pharmacokinetics
  • Bioequivalence
  • Sumatriptan (via Intraject System)
  • Dallas, Texas
    Covance, Inc
Nov 8, 2022

Pharmacokinetics Trial in Fargo (PrimeC-ER 748 mg, Ciprofloxacin 750 MG, Celecoxib 200mg)

Completed
  • Pharmacokinetics
  • PrimeC-ER 748 mg
  • +2 more
  • Fargo, North Dakota
    Novum
Oct 23, 2022

Pharmacokinetics Trial in Nanjing (Group 1:YK-1169, Group 2:YK-1169/Placebo Injection, Group 3:YK-1169/Placebo)

Completed
  • Pharmacokinetics
  • Group 1:YK-1169
  • +5 more
  • Nanjing, Jiangsu, China
    辛玉霞
Oct 18, 2022

Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability Trial in Baltimore (Low dose KT07, High dose KT07, Low dose

Completed
  • Healthy Adult Subjects
  • +2 more
  • Low dose KT07
  • +3 more
  • Baltimore, Maryland
    Pharmaron
Oct 13, 2022

Pharmacokinetics Trial in Glendale (ESK-001, Rabeprazole)

Active, not recruiting
  • Pharmacokinetics
  • Glendale, California
    Alumis Central Site
Sep 16, 2022

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Pharmacokinetics, Absorption; Chemicals Trial in West Bend (Bemotrizinol (6%))

Active, not recruiting
  • Pharmacokinetics
  • Absorption; Chemicals
  • Bemotrizinol (6%)
  • West Bend, Wisconsin
    Spaulding Clinical Research LLC
Aug 25, 2022

Pharmacokinetics Trial in Seoul (IY-NT-T, IY-NT-R)

Recruiting
  • Pharmacokinetics
  • Seoul, Gwanak-gu, Korea, Republic of
    H plus Yangji Hospital
Aug 21, 2022

Pharmacokinetics, Hepatic Impairment Trial in Knoxville (MDMA)

Not yet recruiting
  • Pharmacokinetics
  • Hepatic Impairment
  • Knoxville, Tennessee
    Alliance for Multispecialty Research, LLC.
Aug 17, 2022

Safety, Tolerability, Pharmacokinetics Trial in Glendale (AZD7503, Placebo)

Recruiting
  • Safety
  • +3 more
  • Glendale, California
    Research Site
Aug 16, 2022

Malnutrition, Anorexia, Cannabis Trial in Hvidovre (Sativex)

Recruiting
  • Malnutrition
  • +6 more
  • Hvidovre, Denmark
    Clinical Research Centre
Aug 15, 2022

Fibrinogen Plasma Levels After Fibrinogen Administration

Completed
  • Fibrinogen; Deficiency, Acquired
  • PHARMACOKINETICS
  • DATA RECORDING
  • Barcelona, Spain
  • +1 more
Aug 12, 2022

Pharmacokinetics, Safety, Food-drug Interaction Trial in Miami (200 mg resveratrol as JOTROL, 500 mg resveratrol as JOTROL, 700

Completed
Has Results
  • Pharmacokinetics
  • +2 more
  • 200 mg resveratrol as JOTROL
  • +3 more
  • Miami, Florida
    inVentiv Health Clinical Research Services LLC, a Syneos Health
Jul 13, 2022

Pharmacokinetics Trial (Drug concentration measurement)

Not yet recruiting
  • Pharmacokinetics
  • Drug concentration measurement
  • (no location specified)
Aug 4, 2022

Pharmacokinetics Trial in Seoul (SVG101 (T), Afinitor (R))

Completed
  • Pharmacokinetics
  • SVG101 (T)
  • Afinitor (R)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Aug 3, 2022